Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
UBS
Fuji
Healthtrust
Fish and Richardson
Colorcon
McKinsey
Boehringer Ingelheim
Teva

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021098

« Back to Dashboard

NDA 021098 describes YASMIN, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the YASMIN profile page.

The generic ingredient in YASMIN is drospirenone; ethinyl estradiol. There are ten drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
Summary for 021098
Tradename:YASMIN
Applicant:Bayer Hlthcare
Ingredient:drospirenone; ethinyl estradiol
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021098
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
YASMIN drospirenone; ethinyl estradiol TABLET;ORAL-28 021098 NDA AUTHORIZED GENERIC TEVA PHARMACEUTICALS USA, INC. 0555-9131 N 0555-9131-67
YASMIN drospirenone; ethinyl estradiol TABLET;ORAL-28 021098 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-402 N 50419-402-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength3MG;0.03MG
Approval Date:May 11, 2001TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Aug 31, 2020Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021098

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare YASMIN drospirenone; ethinyl estradiol TABLET;ORAL-28 021098-001 May 11, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare YASMIN drospirenone; ethinyl estradiol TABLET;ORAL-28 021098-001 May 11, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Dow
Colorcon
Citi
Merck
Chinese Patent Office
Queensland Health
Johnson and Johnson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.